It is more than 50 years since population newborn screening began. The newborn screening programmes have provided life changing benefits for children who are identified and treated before the devastating effects of serious conditions such as phenylketonuria (PKU) can cause irreversible damage. Durin...

Consult the pubmed abstract To read more about “Phenylketonuria” Orphanet J Rare Dis . 2021 Jan 18;16(1):35. (Source: OrhpaNews 10 May 2021)

The European Alliance for Newborn Screening for Spinal Muscular Atrophy, composed of European patient organisations, academics and the pharmaceutical industry, has published the whitepaper, entitled “Spinal muscular atrophy: screen at birth, save lives”. This whitepaper aims to call all Eur...

The ERN-EuroBloodNet together with EURORDIS created the European Network of Sickle Cell Disease Patients’ Organisations aiming to provide a centralised European point of contact for patients and caregivers. This new patient group started to request to Belgium to include sickle cell disorders ...

The continued development of Newborn Screening within Europe and in the wider International context. It is now more than 50 years since whole population screening for phenylketonuria began in the US and Europe.   This has been widely regarded as an exceptional advance in public health policy offer...